Trials / Completed
CompletedNCT03866291
ESBL in Patients Returning to Sweden With Traveller's Diarrhoea
ESBL-producing Enterobacteriaceae in Patients With Traveller's Diarrhoea- a Prospective Cohort Study.
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 305 (actual)
- Sponsor
- Lund University · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
Patients with traveller's diarrhoea frequently harbour Extended Spectrum Betalactamase (ESBL)-producing Enterobacteriaceae (EPE) returning from EPE-endemic areas. This study investigates to what extent travellers returning to Sweden with traveller's diarrhoea carry ESBL in their stool. The isolates are examined further according to species, phenotype, antibiogram and whole genome sequencing.
Detailed description
Samples sent to the department of clinical microbiology in Lund, Sweden for culture of salmonella, shigella, yersinia or campylobacter are also cultured selectively for ESBL. All patients are contacted by mail with the results. ESBL-positive patients are invited to submit further faecal cultures and blood samples during one year follow up time, to investigate how long the patient is colonized with ESBL.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | No intervention, observational | See above |
Timeline
- Start date
- 2017-02-01
- Primary completion
- 2019-06-20
- Completion
- 2019-06-20
- First posted
- 2019-03-07
- Last updated
- 2019-07-02
Locations
1 site across 1 country: Sweden
Source: ClinicalTrials.gov record NCT03866291. Inclusion in this directory is not an endorsement.